QUBT · Quantum Computing Inc.

Current Thesis

Quantum Computing Inc.’s commercialization story supports a tentative recovery case, resolved by a weekly close above the July 2026 shelf of $8.22 before a weekly close below the July range floor of $7.30. The adjusted reference close was $7.99 on 2026-09-11, still below that shelf. The recovery remains unconfirmed.

These observations establish an increase between settlements; the sample is too small to support a forecast of forced covering. Benzinga short-interest calendar.

As an inference, the narrative is saturated — the generalist coverage cluster dated 2026-08-19 through 2026-08-28 in the September 3 research record and Ascendiant’s 2026-08-26 target increase to $32 have not been followed by a recovery of the $8.22 shelf at the September 11 reference close. A weekly reclaim accompanied by a disclosed commercial order would contradict that assessment.

The September 10 Lake Street conference date has passed. As checked on 2026-09-13, the company news page still lists the August 31 attendance announcement as its latest press release, while separately listing a September 9 interview with the chief executive. This establishes continued publicity without a newer release on that page; it does not establish what was discussed privately at the conference. Company news.

Bullish and bearish views on Quantum Computing Inc.

The model's bull view on Quantum Computing Inc. (QUBT), in brief: Backlog gives commercialization a benchmark. The bear view: Commercial program value remains conditional. Both cases follow in full.

Bull Case

• Backlog gives commercialization a benchmark. The August 10 results release reported approximately $42.5 million of contract backlog at 2026-06-30. Conversion into reported revenue remains the test. Q2 release.
• Manufacturing capacity has been acquired. NHanced closed on 2026-06-23; the August 10 release states consideration of $73.1 million plus up to $72 million contingent on performance and describes Fab 2 as launched ahead of schedule. Q2 release.
• Company liquidity supports execution capacity. The August 10 release reported approximately $1.3 billion of company cash, cash equivalents and investments at 2026-06-30. That balance measures financial resources, not product demand. Q2 release.

Bear Case

• Commercial program value remains conditional. The August 10 release describes the Planck Dynamics framework’s potential value above $10 million as dependent on customer milestones and other conditions. It is not recognized revenue. Q2 release.
• Operating economics remain the obstacle. The Q2 2026 financial figures cited in the September 3 research record showed $5.551 million of revenue, cost of revenue exceeding revenue and a $23.0 million operating loss. Acquisition completion alone does not establish profitable production.
• Short interest has increased again. Benzinga reports 32.31% of float short at the 2026-08-31 settlement and 8.85 days to cover. The latter is a volume-based ratio, not a deadline for covering. Benzinga short-interest calendar.

Setup & Price Structure

The 2026-09-11 adjusted close of $7.99 was above the September 2 close of $7.84, but remained below the July range top of $8.22 identified in the September 3 note. The current supplied price series records a three-month decline of 19.5%, a distance of 67.5% below the $24.62 52-week high, and a 14-day relative strength index (RSI) of 35.6 as of September 11. Those measurements do not establish a completed base.

The September 3 note recorded the 50-day moving average at $8.60 and the 200-day at $9.55 on 2026-09-02. Updated averages are missing, so those figures are historical references rather than current moving resistance. No claim about present distance above or below a rising average is supported.

The defined recovery outcome is a weekly close above $8.22 before the $7.30 weekly-close invalidation. The low-conviction forecast reflects the September 11 failure to regain that shelf and the increased August 31 short-interest count; a large short balance alone does not establish a squeeze.

Catalyst Calendar (next 30 days)

• 2026-09-21 to 2026-09-23 — ECOC exhibition, Málaga. Company participation is listed; a disclosed customer order or delivery would provide commercial evidence beyond attendance. No such announcement is promised by the listing. Company events.
• 2026-09-23 to 2026-09-25 — Quantum World Congress, College Park. The company calendar supplies another public engagement date, without specifying a financial disclosure. Company events.
• 2026-09-28 to 2026-09-30 — Quantum Innovation Summit, Dubai. Participation is listed; the event itself does not resolve backlog conversion. Company events.
• 2026-10-06 to 2026-10-07 — Quantum Effects, Stuttgart. The company lists this appearance within the next month, without a scheduled results announcement. Company events.
• ~2026-11-10, estimated and unconfirmed — Q3 2026 results. This date remains the estimate in the September 3 public note, not a verified company appointment. The report is the later event relevant to testing revenue against Q2’s $5.551 million and whether revenue exceeds cost of revenue.

What Would Change Our Mind

Loss of the July 2026 range floor ends the defined recovery case: a weekly close below $7.30 is the gradeable invalidation. The September 11 close of $7.99 remains above that threshold, but below the $8.22 recovery condition.

Commercial confirmation requires more than the September conference calendar. At the next quarterly report, revenue above Q2 2026’s $5.551 million with cost of revenue below revenue would support the commercialization argument; revenue at or below that comparison with continuing negative gross profit would contradict it. This operating test is separate from the price-defined recovery outcome.

Correlation Notes

This is a single-name recovery case; no current peer-return series supports a measured correlation claim. The August 31 short-interest count and September 11 price structure support discussion of squeeze sensitivity, but cannot establish that QUBT follows another quantum stock.

There is a dated overlap with photonics publicity: Coherent announced on 2026-08-25 that it would unveil PhotonLink at ECOC on 2026-09-21, when QUBT’s listed exhibition participation begins. Shared timing establishes an attention window, not a commercial relationship or correlated return. Coherent announcement.